Kimberly J Bussey

Author PubWeight™ 52.35‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol 2003 22.63
2 Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells. Cancer Cell 2004 3.72
3 Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc Natl Acad Sci U S A 2003 3.66
4 Mistaken identifiers: gene name errors can be introduced inadvertently when using Excel in bioinformatics. BMC Bioinformatics 2004 3.65
5 Karyotypic complexity of the NCI-60 drug-screening panel. Cancer Res 2003 3.42
6 Comparing cDNA and oligonucleotide array data: concordance of gene expression across platforms for the NCI-60 cancer cells. Genome Biol 2003 2.52
7 Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance. Cancer Res 2004 2.10
8 Diagnostic markers that distinguish colon and ovarian adenocarcinomas: identification by genomic, proteomic, and tissue array profiling. Cancer Res 2003 1.51
9 Genomic signatures of cancer: basis for individualized risk assessment, selective staging and therapy. J Surg Oncol 2011 1.48
10 Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells. Mol Cancer Ther 2006 1.41
11 Adrenocortical cancer. Surg Clin North Am 2009 1.17
12 Multifactorial regulation of E-cadherin expression: an integrative study. Mol Cancer Ther 2010 0.97
13 Isotropic 3D nuclear morphometry of normal, fibrocystic and malignant breast epithelial cells reveals new structural alterations. PLoS One 2012 0.97
14 PTTG1 overexpression in adrenocortical cancer is associated with poor survival and represents a potential therapeutic target. Surgery 2013 0.95
15 Whole-genome sequencing of an aggressive BRAF wild-type papillary thyroid cancer identified EML4-ALK translocation as a therapeutic target. World J Surg 2014 0.95
16 Targeted therapies for adrenocortical carcinoma: IGF and beyond. Horm Cancer 2011 0.91
17 Preclinical investigation of nanoparticle albumin-bound paclitaxel as a potential treatment for adrenocortical cancer. Ann Surg 2012 0.78
18 A fly in the ointment: reassessing mitotane's role in the treatment of adrenocortical carcinoma. Pharmacogenomics 2012 0.77
19 Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell 2016 0.76
20 Multi-institutional tumor banking: lessons learned from a pancreatic cancer biospecimen repository. Pancreas 2010 0.75